Patent application number | Description | Published |
20090252661 | Fuel reformer - A fuel reformer includes a reforming portion having a tubular catalytic converter that is composed of a substrate supporting the catalytic component, and is arranged to have a center axis extending along the supply direction of the fuel and oxidizer derived from a supply portion, and a communication passage arranged along an inner wall of the catalytic converter and communicating with the supply portion. The fuel and oxidizer supplied from the supply portion to the communication passage pass from the inner wall of the catalytic converter to an outer wall thereof by forced convection, thereby reforming the fuel. | 10-08-2009 |
20110061299 | Catalytic process and system for converting liquid fuels into syngas - The present invention provides a process and apparatus for the gasification of a liquid fuel and includes providing a supply of a liquid fuel, a supply of oxidant, and a supply of liquid water; atomizing the liquid fuel and mixing it with the oxidant and steam; catalytically reacting the fuel-oxidant-steam mixture in a catalyst bed; initiating the catalytic reaction with an ignition source; positioning a heat exchanger in proximity with the catalyst bed so as to convert the liquid water to steam; and feeding the steam into the catalytic reaction, thereby eliminating the need for a liquid fuel vaporizer. A preferred catalyst bed includes an ultra-short-channel-length metal substrate. | 03-17-2011 |
20130174485 | PROCESS AND APPARATUS FOR REFORMING A HIGH SULFUR-CONTAINING LIQUID FUEL - A reforming process and apparatus exhibiting improved catalyst longevity towards reforming a high sulfur-containing liquid fuel. The process involves contacting in a first reforming zone a first oxidant and a liquid fuel containing high molecular weight organosulfur compounds with a partial oxidation catalyst under CPDX reaction conditions to form a first reformate stream containing a mixture of unconverted and partially-converted hydrocarbons and one or more low molecular weight sulfur compounds; and then contacting in a second reforming zone the first reformate stream with steam and optionally a second oxidant in the presence of an autothermal reforming catalyst under ATR reaction conditions to form a second reformate stream containing carbon monoxide and hydrogen and one or more low molecular weight sulfur compounds. The low molecular weight sulfur compounds can be readily removed from the first and/or second reformate streams by gas phase adsorption methods. | 07-11-2013 |
20130240789 | REACTOR CONTROL METHOD - A method is provided for controlling the operating temperature of a catalytic reactor using a closed-loop system that provides for varying the reactor input and other operating parameters in order to maintain the operating temperature of the reactor at or near the initial setpoint temperature for operation of the reactor. In one example, maximum and minimum operating temperatures with a catalytic partial oxidation reactor are controlled, as well as maintaining control over the corresponding minimum required ratio of oxygen atoms to carbon atoms, such that the operating temperature within the reactor is maintained below the material limits but above threshold temperatures for coking. | 09-19-2013 |
20140017583 | PROCESS OF REFORMING A SULFUR-CONTAINING LIQUID FUEL - A process of reforming a liquid fuel comprising from greater than 50 ppmw sulfur to less than 400 ppmw sulfur, the process comprising contacting a liquid hydrocarbon fuel comprising one or more organosulfur compounds in a concentration from greater than 50 ppmw to less than 400 ppmw sulfur with an oxidant and steam or water, the contacting occurring in a catalyst bed comprising a reforming catalyst deposited on an ultra-short-channel-length metal substrate, such that the process is conducted at a peak catalyst temperature greater than 950° C. so as to produce a reformate mixture comprising hydrogen and carbon monoxide. | 01-16-2014 |
Patent application number | Description | Published |
20090285827 | ANTAGONIST ANTIBODIES AGAINST GDF-8 AND USES IN TREATMENT OF ALS AND OTHER GDF-8 ASSOCIATED DISORDERS - The disclosure provides novel molecules related to growth and differentiation factor-8 (GDF-8), in particular mouse and humanized antibodies, and antibody fragments, including those that inhibit GDF-8 activity and signaling in vitro and/or in vivo. The disclosure also provides methods for diagnosing, treating, ameliorating, preventing, prognosing, or monitoring degenerative orders of muscle, bone, and insulin metabolism, etc., in particular amyotrophic lateral sclerosis (ALS). In addition, the disclosure provides pharmaceutical compositions for the treatment of such disorders by using the antibodies, polypeptides, polynucleotides, and vectors of the invention. | 11-19-2009 |
20120003212 | ANTAGONIST ANTIBODIES AGAINST GDF-8 AND USES IN TREATMENT OF ALS AND OTHER GDF-8 ASSOCIATED DISORDERS - The disclosure provides novel molecules related to growth and differentiation factor-8 (GDF-8), in particular mouse and humanized antibodies, and antibody fragments, including those that inhibit GDF-8 activity and signaling in vitro and/or in vivo. The disclosure also provides methods for diagnosing, treating, ameliorating, preventing, prognosing, or monitoring degenerative orders of muscle, bone, and insulin metabolism, etc., in particular amyotrophic lateral sclerosis (ALS). In addition, the disclosure provides pharmaceutical compositions for the treatment of such disorders by using the antibodies, polypeptides, polynucleotides, and vectors of the invention. | 01-05-2012 |
20120016106 | ANTAGONIST ANTIBODIES AGAINST GDF-8 AND USES IN TREATMENT OF ALS AND OTHER GDF-8 ASSOCIATED DISORDERS - The disclosure provides novel molecules related to growth and differentiation factor-8 (GDF-8), in particular mouse and humanized antibodies, and antibody fragments, including those that inhibit GDF-8 activity and signaling in vitro and/or in vivo. The disclosure also provides methods for diagnosing, treating, ameliorating, preventing, prognosing, or monitoring degenerative orders of muscle, bone, and insulin metabolism, etc., in particular amyotrophic lateral sclerosis (ALS). In addition, the disclosure provides pharmaceutical compositions for the treatment of such disorders by using the antibodies, polypeptides, polynucleotides, and vectors of the invention. | 01-19-2012 |
20130156767 | METHOD FOR TREATING CACHEXIA USING ANTAGONIST ANTIBODIES AGAINST GDF-8 - The disclosure provides novel molecules related to growth and differentiation factor-8 (GDF-8), in particular mouse and humanized antibodies, and antibody fragments, including those that inhibit GDF-8 activity and signaling in vitro and/or in vivo. The disclosure also provides methods for diagnosing, treating, ameliorating, preventing, prognosing, or monitoring degenerative orders of muscle, bone, and insulin metabolism, etc., in particular amyotrophic lateral sclerosis (ALS). In addition, the disclosure provides pharmaceutical compositions for the treatment of such disorders by using the antibodies, polypeptides, polynucleotides, and vectors of the invention. | 06-20-2013 |
20140086920 | Antagonist Antibodies against GDF-8 and Uses in Treatment of ALS and Other GDF-8 Associated Disorders - The disclosure provides novel molecules related to growth and differentiation factor-8 (GDF-8), in particular mouse and humanized antibodies, and antibody fragments, including those that inhibit GDF-8 activity and signaling in vitro and/or in vivo. The disclosure also provides methods for diagnosing, treating, ameliorating, preventing, prognosing, or monitoring degenerative orders of muscle, bone, and insulin metabolism, etc., in particular amyotrophic lateral sclerosis (ALS). In addition, the disclosure provides pharmaceutical compositions for the treatment of such disorders by using the antibodies, polypeptides, polynucleotides, and vectors of the invention. | 03-27-2014 |
20150152176 | ANTAGONIST ANTIBODIES AGAINST GDF-8 - The disclosure provides novel molecules related to growth and differentiation factor-8 (GDF-8), in particular mouse and humanized antibodies, and antibody fragments, including those that inhibit GDF-8 activity and signaling in vitro and/or in vivo. The disclosure also provides methods for diagnosing, treating, ameliorating, preventing, prognosing, or monitoring degenerative orders of muscle, bone, and insulin metabolism, etc., in particular amyotrophic lateral sclerosis (ALS). In addition, the disclosure provides pharmaceutical compositions for the treatment of such disorders by using the antibodies, polypeptides, polynucleotides, and vectors of the invention. | 06-04-2015 |
Patent application number | Description | Published |
20090060743 | Expandable impeller pump - An impeller includes a hub, and a plurality of blades supported by the hub, the blades being arranged in at least two blade rows. The impeller has a deployed configuration in which the blades extend away from the hub, and a stored configuration in which at least one of the blades is radially compressed, for example by folding the blade towards the hub. The impeller may also have an operational configuration in which at least some of the blades are deformed from the deployed configuration upon rotation of the impeller when in the deployed configuration. The outer edge of one or more blades may have a winglet, and the base of the blades may have an associated indentation to facilitate folding of the blades. | 03-05-2009 |
20110004046 | BLOOD PUMP WITH EXPANDABLE CANNULA - A blood pump includes an impeller having a plurality of foldable blades and a cannula having a proximal portion with a fixed diameter, and a distal portion with an expandable diameter. The impeller can reside in the expandable portion of the cannula. The cannula has a collapsed condition for percutaneous delivery to a desired location within the body, and an expanded condition in which the impeller can rotate to pump blood. A flexible drive shaft can extend through the cannula for rotationally driving the impeller within the patient's body. | 01-06-2011 |
20110071338 | HEART ASSIST DEVICE WITH EXPANDABLE IMPELLER PUMP - An impeller includes a hub and at least one blade supported by the hub. The impeller has a stored configuration in which the blade is compressed so that its distal end moves towards the hub, and a deployed configuration in which the blade extends away from the hub. The impeller may be part of a pump for pumping fluids, such as pumping blood within a patient. A blood pump may include a cannula having a proximal portion with a fixed diameter, and a distal portion with an expandable diameter. The impeller may reside in the expandable portion of the cannula. The cannula may have a compressed diameter which allows it to be inserted percutaneously into a patient. Once at a desired location, the expandable portion of the cannula may be expanded and the impeller expanded to the deployed configuration. A flexible drive shaft may extend through the cannula for rotationally driving the impeller within the patient's body. | 03-24-2011 |
20110236210 | EXPANDABLE IMPELLER PUMP - An impeller includes a hub, and a plurality of blades supported by the hub, the blades being arranged in at least two blade rows. The impeller has a deployed configuration in which the blades extend away from the hub, and a stored configuration in which at least one of the blades is radially compressed, for example by folding the blade towards the hub. The impeller may also have an operational configuration in which at least some of the blades are deformed from the deployed configuration upon rotation of the impeller when in the deployed configuration. The outer edge of one or more blades may have a winglet, and the base of the blades may have an associated indentation to facilitate folding of the blades. | 09-29-2011 |
20120172656 | PERCUTANEOUS HEART PUMP - A heart pump and a catheter assembly therefor are provided that include a flexible catheter body having a proximal end and a distal end, the catheter body having a plurality of lumens therethrough. The catheter body can be sufficiently flexible to extend from a peripheral access to a patient's heart. The catheter assembly can also include an impeller assembly having an impeller and a housing. The impeller assembly can be coupled with the flexible catheter body such that a tensile force applied to opposite ends of the catheter assembly enhances the security of the connection between the catheter body and the impeller assembly. | 07-05-2012 |
20130066140 | HEART ASSIST DEVICE WITH EXPANDABLE IMPELLER PUMP - An impeller includes a hub and a blade supported by the hub. The impeller has a stored configuration in which the blade is compressed so that its distal end moves towards the hub, and a deployed configuration in which the blade extends away from the hub. The impeller may be part of a pump for pumping fluids, such as blood, and may include a cannula having a proximal portion with a fixed diameter, and a distal portion with an expandable diameter. The impeller may reside in the expandable portion of the cannula. The cannula may have a compressed diameter which allows it to be inserted percutaneously into a patient. Once at a desired location, the expandable portion of the cannula may be expanded and the impeller expanded to the deployed configuration. A flexible drive shaft may extend through the cannula for rotationally driving the impeller within the patient. | 03-14-2013 |
20130129503 | EXPANDABLE IMPELLER PUMP - An impeller includes a hub, and a plurality of blades supported by the hub, the blades being arranged in at least two blade rows. The impeller has a deployed configuration in which the blades extend away from the hub, and a stored configuration in which at least one of the blades is radially compressed, for example by folding the blade towards the hub. The impeller may also have an operational configuration in which at least some of the blades are deformed from the deployed configuration upon rotation of the impeller when in the deployed configuration. The outer edge of one or more blades may have a winglet, and the base of the blades may have an associated indentation to facilitate folding of the blades. | 05-23-2013 |
20130331639 | BLOOD PUMP WITH EXPANDABLE CANNULA - A blood pump includes an impeller having a plurality of foldable blades and a cannula having a proximal portion with a fixed diameter, and a distal portion with an expandable diameter. The impeller can reside in the expandable portion of the cannula. The cannula has a collapsed condition for percutaneous delivery to a desired location within the body, and an expanded condition in which the impeller can rotate to pump blood. A flexible drive shaft can extend through the cannula for rotationally driving the impeller within the patient's body. | 12-12-2013 |
20150152878 | EXPANDABLE IMPELLER PUMP - An impeller includes a hub, and a plurality of blades supported by the hub, the blades being arranged in at least two blade rows. The impeller has a deployed configuration in which the blades extend away from the hub, and a stored configuration in which at least one of the blades is radially compressed, for example by folding the blade towards the hub. The impeller may also have an operational configuration in which at least some of the blades are deformed from the deployed configuration upon rotation of the impeller when in the deployed configuration. The outer edge of one or more blades may have a winglet, and the base of the blades may have an associated indentation to facilitate folding of the blades. | 06-04-2015 |
Patent application number | Description | Published |
20100312346 | LOW PROFILE INTERVERTEBRAL IMPLANT - The present invention is directed to a low profile intervertebral implant ( | 12-09-2010 |
20110045087 | POROUS BIOCOMPATIBLE POLYMER MATERIAL AND METHODS - Embodiments described include devices and methods for forming a porous polymer material. Devices disclosed and formed using the methods described include a spacer for spinal fusion, craniomaxillofacial (CMF) structures, and other structures for tissue implants. | 02-24-2011 |
20120130494 | ALLOGRAFT INTERVERTEBRAL IMPLANT AND METHOD OF MANUFACTURING THE SAME - The present invention is directed to an allograft intervertebral implant sized and configured for insertion between adjacent vertebral bodies in a spinal fusion surgery. The implant is preferably manufactured from two or more pieces of allograft bone joined together by a joint, more preferably a dovetail joint. The dovetail joint being sized and configured to substantially follow the exterior shape or surface of the intervertebral implant. | 05-24-2012 |
20120323330 | LOW PROFILE INTERVERTEBRAL IMPLANT - The present invention is directed to a low profile intervertebral implant ( | 12-20-2012 |
20130030534 | ALLOGRAFT INTERVERTEBRAL IMPLANT AND METHOD OF MANUFACTURING THE SAME - The present invention is directed to an allograft intervertebral implant sized and configured for insertion between adjacent vertebral bodies in a spinal fusion surgery. The implant is preferably manufactured from two or more pieces of allograft bone joined together by a joint, more preferably a dovetail joint. The dovetail joint being sized and configured to substantially follow the exterior shape or surface of the intervertebral implant. | 01-31-2013 |
20140039628 | ALLOGRAFT INTERVERTEBRAL IMPLANT AND METHOD OF MANUFACTURING THE SAME - The present invention is directed to an allograft intervertebral implant sized and configured for insertion between adjacent vertebral bodies in a spinal fusion surgery. The implant is preferably manufactured from two or more pieces of allograft bone joined together by a joint, more preferably a dovetail joint. The dovetail joint being sized and configured to substantially follow the exterior shape or surface of the intervertebral implant. | 02-06-2014 |
20140171867 | PRIMING METHOD FOR INFUSION DEVICE - Described is drug infusion device and lineset for delivering medication. The novel pump and lineset described herein eliminate the ability of the pump and lineset from being primed when the cartridge reservoir is in fluid communication with the drug-delivering cannula, through which medication is delivered, is inserted into the skin of a patient. The system and method of the invention include a lineset having a plurality of electrical leads for allowing electrical communication between the infusion pump and the infusion set and for allowing the pump to determine whether the lineset is connected to the infusion set when a priming operation is initiated. | 06-19-2014 |
20140207237 | Porous Biocompatible Polymer Material and Methods - Embodiments described include devices and methods for forming a porous polymer material. Devices disclosed and formed using the methods described a spacer for spinal fusion, craniomaxillofacial (CMF) structures, and other structures for tissue implants. | 07-24-2014 |
20150176053 | TEST STRIP INSERTION DRIVE MECHANISM FOR ANALYTE METER - An analyte meter having a test strip port includes a detector proximate the port for detecting a test strip being inserted therein. A drive mechanism connected to the detector is configured to engage and pull a detected test strip into the test meter and into electrical and mechanical engagement therewith to enable analyte tests to be conducted. | 06-25-2015 |
20150177174 | TEST STRIP CONNECTOR CONTACT PROTECTION - A test strip port connector of a test meter receives an analytical test strip comprising a sample chamber for receiving a fluid sample. The fluid sample is prevented from contaminating an interior region of the test strip port connector by a sealing mechanism having a seal configured to be moved into a sealing position across the test strip. | 06-25-2015 |
20150177175 | MULTI-ORIENTATION TEST STRIPE - A test strip having conductive surfaces separated by a spacer layer, wherein the spacer layer is comprised of sections forming a plurality of sample chambers that enable the test strip to be inserted into a test meter in a number of possible orientations. The test strip also includes electrical contact pads on opposing sides thereof such that the test meter may separately engage the contact pads depending on the insertion orientation. | 06-25-2015 |
20150177256 | TEST STRIP SAMPLE APPLICATION VIDEO SYSTEM - An analyte meter having a test strip port includes a camera which is configured to transmit digital images of a test strip in the test strip port for display to facilitate simultaneous application of a sample to the test strip. | 06-25-2015 |
Patent application number | Description | Published |
20090032546 | PILL BOTTLE INCLUDING AN INTERNAL SLEEVE AND AN EXTERNAL SLEEVE - Systems and methods for providing a pill bottle including an internal and external sleeve are provided. A pill bottle according to the invention may include an external sleeve and an internal sleeve. The internal sleeve preferably includes a cavity for holding pills. The external sleeve is slidably coupled to the internal sleeve. The external sleeve may include a groove and the internal sleeve may include a projection that may slide within the groove. The groove may prevent substantial rotation of the external sleeve with respect to the internal sleeve by preventing a substantial rotational of the projection with respect to the groove. | 02-05-2009 |
20090032547 | THREE BUTTON ACTUATED PILL HOLDER/DISPENSER - Systems and methods for providing a three button actuated pill holder/dispenser are provided. Such a pill holder/dispenser may include a housing comprising a plurality of apertures, a top button and two side buttons. In response to actuation of the top button, a pill may be dispensed from the pill holder/dispenser. Preferably, the two side buttons, which may project through the apertures, lock the top button, such that the top button may only be actuated when the two side buttons are depressed. Alternatively, some other sequence of the buttons may be implemented to cause a pill to be actuated. Additionally, the pill holder/dispenser may be packaged in a sealable package. | 02-05-2009 |
20090037221 | SYSTEMS AND METHODS FOR PROVIDING CUSTOMIZABLE PILL BOTTLE SLEEVES - Systems and methods for providing customizable sleeves for pill bottles, customizable adhesive attachments, customizable Post-it notes and methods for the manufacture thereof are provided. Also provided are methods of surveying pharmacists regarding the effect of customizable adhesive attachments to a pill bottle. The method may include using a digital computer to receive information relating to issues in implementation of a system for providing customizable adhesive attachments. The customizable adhesive attachments may be attached to the bottle. The adhesive attachments may be customizable with respect to at least two of 1) color; 2) content; and 3) texture. The method may further include using a digital computer to receive information relating to benefits obtained from the adhesive attachment. | 02-05-2009 |